Make prescribing decisions with our comparative charts and treatment algorithms.
Quickly and accurately perform clinical calculations.
Download or print easy-to-read disease leaflets for your patients.
Get valuable insight on select drug products and medically-relevant topics, courtesy of the pharmaceutical industry.
The DEA's Final Rule moving hydrocodone combination products (HCPs) from Schedule III to Schedule II will go into effect starting October 6, but physicians should be prepared for this change in advance to minimize disruptions in patient treatment plans.
For chronic pain patients being unsuccessfully treated with high-dose full-opioid agonists, switching to sublingual buprenorphine, can provide effective pain management and improve a patient's quality of life.
Migraines in midlife may be associated with increased odds of developing Parkinson's disease or other movement disorders in later years.
The American Orthopaedic Foot & Ankle Society (AOFAS) has released a list of tests and procedures that are commonly ordered but not always necessary.
The number of Americans dying from accidental overdoses of opioid analgesics jumped significantly from 1999-2011, with the highest jump seen in people aged 55-64.
Discussing end-of-life issues and palliative care options with patients who have life-limiting illnesses is challenging. ...
This program will discuss the causes of chronic pain as well as pharmacological options for ...
This course offers practicing physicians, mid-level practitioners, nurses and other allied health professionals a comprehensive ...